Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

Clinical trial NCT06391892 · RECRUITING

Trial details

NCT number: NCT06391892
Sponsor: Elisabethinen Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Circulating Tumor Cell Predictive Cancer Model

Start date: 2024-01-11
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.